drugset / Trial / NCT02229461
Naproxen Sodium/ASA Platelet Study
RandomizedParallel-groupOpen-labelTreatment
Summary
To determine if administration of naproxen sodium 220 mg maintains the platelet inhibitory effect of a low dose Immediate Release Aspirin (IR ASA) regimen.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 81 mg | — |
| Subject | Naproxen | Small molecule | 220 mg | — |